Publications by authors named "Russell D Cohen"

Claim this Profile
C
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease.
Nikhil Reddy, Jeremy A Klein, Nikita Thomas, Dejan Micic, Zifeng Deng, Russell D Cohen

Clin Transl Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food for Thought: EEN as Adjunct Bridge Therapy in Adult Crohn's with Strictures.
Emma Levine, Russell D Cohen, Tenzin Choden

Dig Dis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series.
Yusuke Miyatani, David Choi, Andrew I Aronsohn, Anjana Pillai, Russell D Cohen

Dig Dis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A positive test does not impact outcomes in hospitalized patients with acute severe ulcerative colitis.
Geethanjali Rajagopal, Raghavendra Paknikar, Zifeng Deng, Sujaata Dwadasi, Donald V Goens, Russell D Cohen

Therap Adv Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease.
Adar Zinger, David Choi, Natalie Choi, Evan Fear, Zachary Fine, Russell D Cohen

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease.
Agnes H Y Ho, David Choi, Alex J Mathew, Alexandra McDermott, Zachary Fine, Russell D Cohen

Clin Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review.
Piotr Wiland, Charlotte Both, Norman B Gaylis, Russell D Cohen, Jonas Halfvarson

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.
Joëlle St-Pierre, David Choi, Evan Fear, Natalie K Choi, Alex J Mathew, Russell D Cohen

Dig Dis Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review.
Piotr Wiland, Charlotte Both, Norman B Gaylis, Russell D Cohen, Jonas Halfvarson

Adv Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease.
Gionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, Raymond K Cross, Parakkal Deepak

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.
Shintaro Akiyama, Jacob E Ollech, Nathaniel A Cohen, Cindy Traboulsi, Victoria Rai, Russell D Cohen

Inflamm Bowel Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial.
Russell D Cohen

Curr Opin Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Analysis of Clinical Symptoms and Modified Pouchitis Disease Activity Index Among Endoscopic Phenotypes of the J Pouch in Patients With Inflammatory Bowel Disease.
Shintaro Akiyama, Nathaniel A Cohen, Jacob E Ollech, Cindy Traboulsi, Tina Rodriguez, Russell D Cohen

Crohns Colitis 360· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center.
Adar Zinger, David Choi, Natalie Choi, Russell D Cohen, David T Rubin

Clin Gastroenterol Hepatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Nathaniel A Cohen, David Choi, Nicole Garcia, Natalie K Choi, Emma Picker, Russell D Cohen

Dig Dis Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
David K Choi, Nathaniel A Cohen, Tenzin Choden, Russell D Cohen, David T Rubin

Inflamm Bowel Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digging into the Histology.
Raghavendra Paknikar, Lindsay Alpert, Russell D Cohen, Benjamin Shogan, Dejan Micic

N Engl J Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.
Omar K Jamil, Dustin Shaw, Zifeng Deng, Nicholas Dinardi, Natalie Fillman, Russell D Cohen

Therap Adv Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Scott Friedberg, David Choi, Thomas Hunold, Natalie K Choi, Nicole M Garcia, Nathaniel A Cohen, Russell D Cohen

Clin Gastroenterol Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis.
Tenzin Choden, Russell D Cohen

Dig Dis Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
Dustin G Shaw, Raúl Aguirre-Gamboa, Marcos C Vieira, Saideep Gona, Nicholas DiNardi, Russell D Cohen

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
Nathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, Cindy Traboulsi, Tina G Rodriguez, Russell D Cohen

Dig Dis Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis.
Nathaniel A Cohen, Maryam Zafer, Namrata Setia, Michael J Anderson, Atsushi Sakuraba, Russell D Cohen

Dig Dis Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis.
Vipul Jairath, Russell D Cohen, Edward V Loftus, Ninfa Candela, Karen Lasch

BMC Gastroenterol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis.
Tenzin Choden, Mia Yeager, Russell D Cohen

Dig Dis Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis